You are here: Industry Insights > IPO

News List

Stealth BioTherapeutics shoots for $86M IPO to target mitochondrial dysfunction fiercebiotech
January 04, 2019
Stealth BioTherapeutics filed on Friday to raise up to $86 million in its Nasdaq IPO, funding that will push its lead asset through the clinic in multiple indications......
Moderna’s cash juggernaut rolls on with record $604M IPO fiercebiotech
December 28, 2018
Moderna’s IPO always looked like a record breaker for biotech and came in even larger than expected at $604 million, valuing the company at an eye-watering $7.9 billion.....
DiaMedica pulls off IPO to fund midphase stroke trial fiercebiotech
December 28, 2018
DiaMedica Therapeutics has wrapped up its IPO. The offering gives DiaMedica the cash to take its lead candidate through phase 2 trials in acute ischemic stroke (AIS) and chronic kidney disease (CKD).....
Junshi Biosciences aims for $414M Hong Kong, S.A.R., China IPO: Reuters fiercebiotech
December 28, 2018
China’s Junshi Biosciences may follow in compatriot Innovent Biologics’ footsteps as it tees up to raise $414 million in its Hong Kong, S.A.R., China IPO....
4 years after mega IPO, Circassia set for small-cap exchange fiercebiotech
December 27, 2018
Four years ago, Circassia looked to have ushered in a new era for biotech IPOs on the London Stock Exchange when it raised £200 million ($252 million) to.....
Biofrontera cleared of wrongdoing in Nasdaq IPO fiercebiotech
December 26, 2018
An independent review has cleared Biofrontera of wrongdoing related to its U.S. IPO. Shareholders had accused Biofrontera of acting contrary to its duties when it priced and sold stock in the U.S.....
GE Healthcare files confidential IPO listing: report fiercebiotech
December 25, 2018
General Electric has submitted a confidential filing to spin out its healthcare business into a publicly traded company, with an IPO likely taking place early next year, according to a report from Bloomberg....
Europe's biggest private biotech company raises $270 million biospectrumasia
December 24, 2018
Europe’s largest privately held biotech company, Germany-based BioNTech, has raised $270 million to support its work in developing personalized immunotherapies for cancer, ahead of an expected eventual stock market flotation.
WuXi AppTec eyes acquisitions after $1bn Hong Kong, S.A.R., China IPO pharmaphorum
December 17, 2018
Chinese biotech WuXi AppTec has completed its listing on Hong Kong, S.A.R., China’s HKEX, raising $967m just months after making its debut on the Shanghai exchange.
Secretive Moderna could finally go public with $500m IPO pharmaphorum
December 12, 2018
RNA medicine specialist Moderna is attempting the biggest IPO in biotech history, after applying to raise $500 million from investors.

Previous page 1 2 3 4 5 6 7 8 9 Next page